Explore detailed financial insights for NSE: Genesys International Corporation Limited, including share price, quarterly results, governance, and stock forecasts for 2025.

NSE: Genesys International Corporation Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept

Stay informed with the latest announcements for Genesys, including updates on board meetings and corporate actions.

GENESYS
Genesys International Corporation Limited - https://www.igenesys.com
Genesys International Corporation Limited provides geographical information services in India and internationally. The company offers photogrammetry, remote sensing, cartography, data conversion, state of the art terrestrial; and 3D geocontent, including location navigation mapping and other computer based related services. It also provides 3D Digital Twin services; terrestrial, backpack, mobile, and aerial LiDAR scanners; geospatial services, such as data capture, conversion, processing, integration, maintenance, and update; WoNoBo platform; HD maps/ADAS; 3D and HD mapping services, and AI machine learning; and application development services, including enterprise GIS and web-based application, mobile app development, and system integration services for public and private enterprises, and consumers. In addition, the company offers building information modeling services; and business consulting services, including requirement analysis, project design and planning, project management, GIS orientation seminar and workshop, and database and application design with system configuration. Further, the company provides various solutions, such as TeleSCAPE, GaSCAPE, InfraSCAPE, CitySCAPE, WaterSCAPE, and market analysis and route planning system. It provides its services to the automotive, urban development, telecom, electric, gas, water supply and sanitization, infrastructure, navigation, and disaster management industries. Genesys International Corporation Limited was incorporated in 1983 and is headquartered in Mumbai, India.

Genesys International Corporation Limited Share Price Today

815.00
OPEN
826.70
HIGH
795.50
LOW
810.75
CLOSE
233 K
VOLUME
3,651 Cr
Market Cap
466322
Average Volume
Technology
Sector
NSI
Exchange

Genesys International Corporation Limited Share Analysis & 2025 Insights

// -->

Investor Presentations

Date Description Download
SIP
Lumpsum
₹25,000
12%
10 Yr

Invested Amount: ₹

Estimated Returns: ₹

Total Value: ₹

NSE: GENESYS Stock Actions

Company
Symbol
ISIN
Subject
Ex Date
Face Value
Broadcast Date
Genesys International Corporation Limited
GENESYS
INE727B01018
Annual General Meeting
23 Sep 2024
5
N/A
Genesys International Corporation Limited
GENESYS
INE727B01018
Annual General Meeting
21 Sep 2023
5
N/A
Genesys International Corporation Limited
GENESYS
INE727B01018
Annual General Meeting
22 Sep 2022
5
N/A
Genesys International Corporation Limited
GENESYS
INE727B01018
Annual General Meeting
22 Sep 2021
5
N/A
Genesys International Corporation Limited
GENESYS
INE727B01018
Annual General Meeting
18 Sep 2020
5
N/A

NSE: GENESYS Recent Announcements

Symbol
Date
Description
Industry
GENESYS
02 Jan 2025, 19:16:28
Updates
Computers - Software
GENESYS
02 Jan 2025, 19:13:33
Alteration Of Capital and Fund Raising-XBRL
Computers - Software
GENESYS
02 Jan 2025, 19:08:32
Updates
Computers - Software
GENESYS
31 Dec 2024, 17:07:16
Trading Window-XBRL
Computers - Software
GENESYS
31 Dec 2024, 17:05:36
Trading Window
Computers - Software

NSE: GENESYS Corporate Governance

Name
Symbol
Timestamp
Submission Date
XBRL Document
Genesys International Corporation Limited
GENESYS
18 Oct 2024, 15:14:00
18 Oct 2024, 15:14:00
Genesys International Corporation Limited
GENESYS
19 Jul 2024, 14:25:00
19 Jul 2024, 14:25:00
Genesys International Corporation Limited
GENESYS
19 Apr 2024, 16:52:00
19 Apr 2024, 17:15:00
Genesys International Corporation Limited
GENESYS
19 Jan 2024, 15:45:00
19 Jan 2024, 16:15:00
Genesys International Corporation Limited
GENESYS
19 Oct 2023, 17:45:00
19 Oct 2023, 18:15:00

NSE: GENESYS Detailed Governance

Category
Date of Birth
Date of Initial Appointment
DIN
Director Name
Status
Chairperson Related To Promoters,Executive Director-MD
01 Apr 1964
17 Jan 2000
00400366
Sajid Siraj Malik
Active
Non-Executive Director
07 Mar 1954
31 Mar 2024
07976475
Omprakash Sanwaldas Hemrajani
Active
Independent Director
14 Mar 1965
29 Sep 2014
00702346
Ganesh Yadava Acharya
Active
Independent Director
12 Jul 1964
24 Dec 2019
03051315
Manish Patel
Active
Independent Director
08 Dec 1958
12 Aug 2022
07985813
Bharti Sinha
Active

NSE: GENESYS Board Meetings

Purpose
Symbol
Industry
ISIN
Name
Time
GENESYS INTERNATIONAL CORPORATION LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Other business.
GENESYS
N/A
INE727B01018
Genesys International Corporation Limited
22 Oct 2024, 17:57:34
Financial Results
GENESYS
N/A
INE727B01018
Genesys International Corporation Limited
08 Aug 2024, 16:53:22
Financial Results/Other business matters
GENESYS
N/A
INE727B01018
Genesys International Corporation Limited
24 May 2024, 17:06:06
GENESYS INTERNATIONAL CORPORATION LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2023 and Other business.
GENESYS
N/A
INE727B01018
Genesys International Corporation Limited
08 Feb 2024, 17:11:02
Financial Results/Other business matters
GENESYS
N/A
INE727B01018
Genesys International Corporation Limited
27 Oct 2023, 18:41:03

NSE: GENESYS Event Calendar

Purpose
Symbol
Industry
ISIN
Name
Time
Description
Financial Results
GENESYS
-
INE727B01018
Genesys International Corporation Limited
22 Oct 2024, 00:00:00
To consider and approve the financial results (standalone and consolidated) for the quarter and half year ended September 30, 2024.
Financial Results
GENESYS
-
INE727B01018
Genesys International Corporation Limited
08 Aug 2024, 00:00:00
GENESYS INTERNATIONAL CORPORATION LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2024 to consider and approve the Un-audited Financial results of the Company for the period ended June 2024 and Other business.
Financial Results/Other business matters
GENESYS
-
INE727B01018
Genesys International Corporation Limited
24 May 2024, 00:00:00
GENESYS INTERNATIONAL CORPORATION LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2024 to consider and approve the Audited Financial results of the Company for the quarter and financial year ended 31-March-2024 and Other business
Financial Results
GENESYS
-
INE727B01018
Genesys International Corporation Limited
08 Feb 2024, 00:00:00
To consider and approve the financial results for the period ended December 31, 2023
Financial Results/Other business matters
GENESYS
-
INE727B01018
Genesys International Corporation Limited
27 Oct 2023, 00:00:00
To consider and approve the financial results for the period ended September 30, 2023 and other business matters

NSE: GENESYS Balance Sheet Data In (Cr)

date period_type Ordinary Shares Number Share Issued Net Debt Total Debt Tangible Book Value Invested Capital Working Capital Net Tangible Assets Capital Lease Obligations Common Stock Equity Total Capitalization Total Equity Gross Minority Interest Minority Interest Stockholders Equity Other Equity Interest Retained Earnings Additional Paid In Capital Capital Stock Common Stock Total Liabilities Net Minority Interest Total Non Current Liabilities Net Minority Interest Other Non Current Liabilities Non Current Pension And Other Postretirement Benefit Plans Long Term Debt And Capital Lease Obligation Long Term Capital Lease Obligation Long Term Debt Long Term Provisions Current Liabilities Other Current Liabilities Current Deferred Taxes Liabilities Current Debt And Capital Lease Obligation Current Capital Lease Obligation Current Debt Pensionand Other Post Retirement Benefit Plans Current Current Provisions Payables Other Payable Dividends Payable Total Tax Payable Accounts Payable Total Assets Total Non Current Assets Other Non Current Assets Non Current Prepaid Assets Non Current Deferred Taxes Assets Investmentin Financial Assets Held To Maturity Securities Available For Sale Securities Financial Assets Designatedas Fair Value Through Profitor Loss Long Term Equity Investment Investmentsin Associatesat Cost Goodwill And Other Intangible Assets Other Intangible Assets Goodwill Net PPE Accumulated Depreciation Gross PPE Construction In Progress Other Properties Machinery Furniture Equipment Buildings And Improvements Properties Current Assets Other Current Assets Restricted Cash Prepaid Assets Other Receivables Taxes Receivable Accounts Receivable Allowance For Doubtful Accounts Receivable Gross Accounts Receivable Cash Cash Equivalents And Short Term Investments Other Short Term Investments Cash And Cash Equivalents Cash Equivalents Cash Financial
2024-09-30T00:00:00 quarterly 39,634,164.00 39,634,164.00 549,473,000.00 734,301,000.00 2,995,353,000.00 5,698,419,000.00 2,104,720,000.00 2,995,353,000.00 138,206,000.00 5,102,324,000.00 5,273,923,000.00 5,116,360,000.00 14,036,000.00 5,102,324,000.00 4,904,153,000.00 0.00 0.00 198,171,000.00 198,171,000.00 1,642,882,000.00 357,032,000.00 0.00 0.00 269,445,000.00 97,846,000.00 171,599,000.00 87,587,000.00 1,285,850,000.00 96,611,000.00 0.00 464,856,000.00 40,360,000.00 424,496,000.00 0.00 30,912,000.00 435,873,000.00 0.00 0.00 86,422,000.00 349,451,000.00 6,759,242,000.00 3,368,672,000.00 48,373,000.00 0.00 205,561,000.00 250,881,000.00 0.00 250,881,000.00 0.00 0.00 0.00 2,106,971,000.00 2,106,971,000.00 0.00 754,003,000.00 0.00 754,003,000.00 8,450,000.00 745,553,000.00 0.00 0.00 0.00 3,390,570,000.00 143,550,000.00 0.00 0.00 360,000.00 0.00 1,530,430,000.00 0.00 0.00 1,716,230,000.00 1,669,608,000.00 46,622,000.00 0.00 0.00
2024-03-31T00:00:00 quarterly 39,540,634.00 39,540,634.00 286,017,000.00 595,178,000.00 2,962,360,000.00 5,410,312,000.00 2,224,668,000.00 2,962,360,000.00 76,487,000.00 4,891,621,000.00 5,112,986,000.00 4,907,779,000.00 16,158,000.00 4,891,621,000.00 5,175,000.00 723,669,000.00 3,344,148,000.00 197,703,000.00 197,703,000.00 1,438,248,000.00 349,735,000.00 0.00 77,962,000.00 271,773,000.00 50,408,000.00 221,365,000.00 77,962,000.00 1,088,513,000.00 95,075,000.00 0.00 323,405,000.00 26,079,000.00 297,326,000.00 31,972,000.00 31,972,000.00 687,360,000.00 298,340,000.00 44,000.00 92,491,000.00 296,485,000.00 6,346,027,000.00 3,032,846,000.00 38,608,000.00 67,411,000.00 221,360,000.00 0.00 0.00 74,232,000.00 0.00 0.00 0.00 1,929,261,000.00 1,929,261,000.00 0.00 757,161,000.00 -1,150,902,000.00 1,908,063,000.00 0.00 816,612,000.00 857,717,000.00 233,734,000.00 0.00 3,313,181,000.00 113,339,000.00 537,029,000.00 144,203,000.00 968,710,000.00 0.00 1,426,705,000.00 -70,908,000.00 1,497,613,000.00 236,534,000.00 3,860,000.00 232,674,000.00 59,131,000.00 173,543,000.00
2024-03-31T00:00:00 annual 39,540,634.00 39,540,634.00 286,017,000.00 595,178,000.00 2,962,360,000.00 5,410,312,000.00 2,224,668,000.00 2,962,360,000.00 76,487,000.00 4,891,621,000.00 5,112,986,000.00 4,907,779,000.00 16,158,000.00 4,891,621,000.00 5,175,000.00 723,669,000.00 3,344,148,000.00 197,703,000.00 197,703,000.00 1,438,248,000.00 349,735,000.00 0.00 77,962,000.00 271,773,000.00 50,408,000.00 221,365,000.00 77,962,000.00 1,088,513,000.00 95,075,000.00 0.00 323,405,000.00 26,079,000.00 297,326,000.00 31,972,000.00 31,972,000.00 687,360,000.00 298,340,000.00 44,000.00 92,491,000.00 296,485,000.00 6,346,027,000.00 3,032,846,000.00 38,608,000.00 67,411,000.00 221,360,000.00 0.00 0.00 74,232,000.00 0.00 0.00 0.00 1,929,261,000.00 1,929,261,000.00 0.00 757,161,000.00 -1,150,902,000.00 1,908,063,000.00 0.00 816,612,000.00 857,717,000.00 233,734,000.00 0.00 3,313,181,000.00 113,339,000.00 537,029,000.00 144,203,000.00 968,710,000.00 0.00 1,426,705,000.00 -70,908,000.00 1,497,613,000.00 236,534,000.00 3,860,000.00 232,674,000.00 59,131,000.00 173,543,000.00
2023-09-30T00:00:00 quarterly 37,804,764.00 37,804,764.00 254,205,000.00 354,139,000.00 2,200,048,000.00 4,287,161,000.00 1,341,259,000.00 2,200,048,000.00 72,048,000.00 4,005,070,000.00 4,180,944,000.00 4,023,409,000.00 18,339,000.00 4,005,070,000.00 3,816,046,000.00 0.00 0.00 189,024,000.00 189,024,000.00 1,039,319,000.00 303,089,000.00 0.00 0.00 229,200,000.00 53,326,000.00 175,874,000.00 73,889,000.00 736,230,000.00 14,852,000.00 0.00 124,939,000.00 18,722,000.00 106,217,000.00 0.00 30,440,000.00 300,374,000.00 0.00 0.00 3,282,000.00 297,092,000.00 5,062,728,000.00 2,985,239,000.00 84,865,000.00 0.00 267,268,000.00 27,239,000.00 0.00 27,239,000.00 0.00 0.00 0.00 1,805,022,000.00 1,805,022,000.00 0.00 773,121,000.00 0.00 773,121,000.00 173,042,000.00 600,079,000.00 0.00 0.00 0.00 2,077,489,000.00 124,291,000.00 0.00 0.00 512,000.00 0.00 885,661,000.00 0.00 0.00 1,067,025,000.00 1,039,139,000.00 27,886,000.00 0.00 0.00
2023-03-31T00:00:00 quarterly 37,755,099.00 37,755,099.00 198,212,000.00 393,177,000.00 2,490,398,000.00 4,377,964,000.00 1,743,664,000.00 2,490,398,000.00 69,330,000.00 4,054,117,000.00 4,227,546,000.00 4,074,868,000.00 20,751,000.00 4,054,117,000.00 187,761,000.00 595,922,000.00 2,573,272,000.00 188,775,000.00 188,775,000.00 981,336,000.00 290,570,000.00 0.00 72,427,000.00 218,143,000.00 44,714,000.00 173,429,000.00 72,427,000.00 690,766,000.00 30,696,000.00 0.00 175,034,000.00 24,616,000.00 150,418,000.00 27,324,000.00 27,324,000.00 488,408,000.00 253,773,000.00 55,000.00 12,306,000.00 222,274,000.00 5,056,204,000.00 2,621,774,000.00 -1,000.00 88,403,000.00 269,034,000.00 0.00 0.00 26,491,000.00 0.00 0.00 0.00 1,563,719,000.00 1,563,719,000.00 0.00 658,816,000.00 -977,077,000.00 1,635,893,000.00 75,413,000.00 619,536,000.00 789,888,000.00 151,056,000.00 0.00 2,434,430,000.00 129,975,000.00 68,545,000.00 143,842,000.00 749,073,000.00 0.00 832,194,000.00 -68,351,000.00 900,545,000.00 640,776,000.00 515,141,000.00 125,635,000.00 0.00 125,635,000.00
2023-03-31T00:00:00 annual 37,755,099.00 37,755,099.00 198,212,000.00 393,177,000.00 2,490,398,000.00 4,377,964,000.00 1,743,664,000.00 2,490,398,000.00 69,330,000.00 4,054,117,000.00 4,227,546,000.00 4,074,868,000.00 20,751,000.00 4,054,117,000.00 187,761,000.00 595,922,000.00 2,573,272,000.00 188,775,000.00 188,775,000.00 981,336,000.00 290,570,000.00 0.00 72,427,000.00 218,143,000.00 44,714,000.00 173,429,000.00 72,427,000.00 690,766,000.00 30,696,000.00 0.00 175,034,000.00 24,616,000.00 150,418,000.00 27,324,000.00 27,324,000.00 488,408,000.00 253,773,000.00 55,000.00 12,306,000.00 222,274,000.00 5,056,204,000.00 2,621,774,000.00 -1,000.00 88,403,000.00 269,034,000.00 0.00 0.00 26,491,000.00 0.00 0.00 0.00 1,563,719,000.00 1,563,719,000.00 0.00 658,816,000.00 -977,077,000.00 1,635,893,000.00 75,413,000.00 619,536,000.00 789,888,000.00 151,056,000.00 0.00 2,434,430,000.00 129,975,000.00 68,545,000.00 143,842,000.00 749,073,000.00 0.00 832,194,000.00 -68,351,000.00 900,545,000.00 640,776,000.00 515,141,000.00 125,635,000.00 0.00 125,635,000.00
2022-03-31T00:00:00 annual 31,362,752.00 31,362,752.00 0.00 265,003,000.00 801,276,000.00 2,250,050,000.00 549,829,000.00 801,276,000.00 63,037,000.00 2,048,084,000.00 2,061,343,000.00 2,358,727,000.00 310,643,000.00 2,048,084,000.00 189,407,000.00 833,058,000.00 526,517,000.00 156,814,000.00 156,814,000.00 831,483,000.00 100,952,000.00 0.00 59,654,000.00 41,298,000.00 28,039,000.00 13,259,000.00 59,654,000.00 730,531,000.00 26,177,000.00 0.00 223,705,000.00 34,998,000.00 188,707,000.00 22,947,000.00 22,947,000.00 483,879,000.00 241,596,000.00 85,000.00 2,358,000.00 239,840,000.00 3,190,210,000.00 1,909,850,000.00 2,406,000.00 6,710,000.00 273,258,000.00 0.00 0.00 27,386,000.00 0.00 0.00 0.00 1,246,808,000.00 1,246,808,000.00 0.00 324,649,000.00 -882,315,000.00 1,206,964,000.00 59,927,000.00 416,108,000.00 606,826,000.00 124,103,000.00 0.00 1,280,360,000.00 91,686,000.00 8,865,000.00 70,254,000.00 434,100,000.00 0.00 491,460,000.00 -33,424,000.00 524,884,000.00 275,681,000.00 61,872,000.00 213,809,000.00 1,006,000.00 213,809,000.00
2021-03-31T00:00:00 annual 31,225,712.00 31,225,712.00 52,533,000.00 136,065,000.00 70,315,000.00 1,799,436,000.00 385,301,000.00 70,315,000.00 69,718,000.00 1,733,089,000.00 1,741,490,000.00 2,549,311,000.00 816,222,000.00 1,733,089,000.00 1,576,960,000.00 814,791,000.00 515,588,000.00 156,129,000.00 156,129,000.00 491,618,000.00 124,233,000.00 40,000.00 72,957,000.00 51,276,000.00 42,875,000.00 8,401,000.00 72,957,000.00 367,385,000.00 15,044,000.00 0.00 84,789,000.00 26,843,000.00 57,946,000.00 23,840,000.00 23,840,000.00 255,374,000.00 125,502,000.00 56,000.00 0.00 129,816,000.00 3,040,929,000.00 2,288,243,000.00 11,721,000.00 24,812,000.00 289,806,000.00 0.00 0.00 13,092,000.00 0.00 0.00 0.00 1,662,774,000.00 1,320,571,000.00 342,203,000.00 273,818,000.00 -792,431,000.00 1,066,249,000.00 0.00 398,884,000.00 547,745,000.00 119,620,000.00 0.00 752,686,000.00 55,472,000.00 15,712,000.00 60,972,000.00 257,520,000.00 31,375,000.00 322,951,000.00 -81,295,000.00 322,951,000.00 95,531,000.00 81,717,000.00 13,814,000.00 2,077,000.00 11,737,000.00
2020-03-31T00:00:00 annual 0.00 0.00 61,810,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 17,324,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

NSE: GENESYS Cash Flow Data In (Cr)

date period_type Free Cash Flow Repayment Of Debt Issuance Of Debt Issuance Of Capital Stock Capital Expenditure End Cash Position Other Cash Adjustment Outside Changein Cash Beginning Cash Position Changes In Cash Financing Cash Flow Net Other Financing Charges Interest Paid Cff Cash Dividends Paid Common Stock Dividend Paid Net Common Stock Issuance Common Stock Issuance Net Issuance Payments Of Debt Net Short Term Debt Issuance Net Long Term Debt Issuance Long Term Debt Payments Long Term Debt Issuance Investing Cash Flow Net Other Investing Changes Interest Received Cfi Net Investment Purchase And Sale Sale Of Investment Purchase Of Investment Net Business Purchase And Sale Purchase Of Business Net Intangibles Purchase And Sale Purchase Of Intangibles Net PPE Purchase And Sale Sale Of PPE Purchase Of PPE Capital Expenditure Reported Operating Cash Flow Taxes Refund Paid Change In Working Capital Change In Other Current Liabilities Change In Other Current Assets Change In Payable Change In Receivables Other Non Cash Items Stock Based Compensation Provisionand Write Offof Assets Depreciation And Amortization Amortization Cash Flow Depreciation Pension And Employee Benefit Expense Gain Loss On Investment Securities Net Foreign Currency Exchange Gain Loss Gain Loss On Sale Of PPE Net Income From Continuing Operations
2024-03-31T00:00:00 annual -645,821,000.00 -72,312,000.00 161,177,000.00 585,179,000.00 -836,494,000.00 232,674,000.00 0.00 125,635,000.00 107,039,000.00 712,433,000.00 0.00 -39,095,000.00 0.00 0.00 585,179,000.00 585,179,000.00 194,845,000.00 105,980,000.00 88,865,000.00 -72,312,000.00 161,177,000.00 -796,067,000.00 0.00 5,709,000.00 30,275,000.00 1,334,912,000.00 -1,304,637,000.00 0.00 0.00 -102,027,000.00 -102,027,000.00 -732,916,000.00 1,551,000.00 -734,467,000.00 0.00 190,673,000.00 -20,494,000.00 -658,168,000.00 111,210,000.00 -255,305,000.00 93,249,000.00 -607,322,000.00 20,941,000.00 31,583,000.00 2,556,000.00 444,802,000.00 219,451,000.00 225,351,000.00 0.00 -11,047,000.00 10,296,000.00 -1,551,000.00 371,755,000.00
2023-03-31T00:00:00 annual -1,331,538,000.00 -25,951,000.00 235,952,000.00 2,091,292,000.00 -979,619,000.00 125,635,000.00 0.00 213,809,000.00 -88,174,000.00 2,148,594,000.00 0.00 -42,676,000.00 0.00 0.00 2,091,292,000.00 2,091,292,000.00 140,017,000.00 -69,984,000.00 210,001,000.00 -25,951,000.00 235,952,000.00 -1,884,849,000.00 0.00 4,120,000.00 -377,035,000.00 1,430,232,000.00 -1,807,267,000.00 -532,583,000.00 -532,583,000.00 -127,731,000.00 -127,731,000.00 -851,888,000.00 0.00 -851,888,000.00 0.00 -351,919,000.00 -66,232,000.00 -935,482,000.00 16,849,000.00 -584,790,000.00 -20,826,000.00 -346,715,000.00 -58,545,000.00 26,862,000.00 34,927,000.00 375,298,000.00 0.00 375,298,000.00 0.00 -23,993,000.00 44,320,000.00 -20,000.00 249,956,000.00
2022-03-31T00:00:00 annual -50,217,000.00 0.00 0.00 33,827,000.00 -331,369,000.00 213,809,000.00 0.00 13,815,000.00 199,994,000.00 119,068,000.00 0.00 -19,019,000.00 0.00 0.00 33,827,000.00 33,827,000.00 135,619,000.00 130,761,000.00 4,858,000.00 0.00 0.00 -200,226,000.00 6,356,000.00 1,824,000.00 27,232,000.00 413,297,000.00 -386,065,000.00 0.00 0.00 -141,690,000.00 -141,690,000.00 -83,551,000.00 106,128,000.00 -189,679,000.00 0.00 281,152,000.00 -26,261,000.00 36,941,000.00 269,656,000.00 -194,325,000.00 131,893,000.00 -170,283,000.00 -51,800,000.00 14,166,000.00 -55,725,000.00 191,257,000.00 0.00 191,257,000.00 14,165,000.00 -1,235,000.00 -11,292,000.00 0.00 -358,685,000.00
2021-03-31T00:00:00 annual 95,004,000.00 0.00 0.00 2,132,000.00 -92,818,000.00 13,814,000.00 0.00 27,362,000.00 -13,548,000.00 -81,493,000.00 -27,403,000.00 -29,158,000.00 0.00 0.00 2,132,000.00 2,132,000.00 -20,196,000.00 -15,762,000.00 -4,434,000.00 0.00 0.00 -119,877,000.00 1,000.00 1,616,000.00 -29,203,000.00 483,082,000.00 -512,285,000.00 0.00 0.00 -14,535,000.00 -14,535,000.00 -77,756,000.00 527,000.00 -78,283,000.00 0.00 187,822,000.00 -16,986,000.00 136,442,000.00 -1,932,000.00 97,907,000.00 -37,322,000.00 77,789,000.00 -73,296,000.00 0.00 63,702,000.00 187,656,000.00 0.00 187,656,000.00 -2,013,000.00 -3,951,000.00 110,779,000.00 -527,000.00 -544,435,000.00
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 2,000.00 0.00 0.00 0.00 84,590,000.00 0.00 -4,692,000.00 -4,692,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -6,403,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 143,000.00 0.00 -48,805,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -43,519,000.00 0.00 0.00 0.00 0.00

NSE: GENESYS Income Statement Data In (Cr)

date period_type Tax Effect Of Unusual Items Tax Rate For Calcs Normalized EBITDA Total Unusual Items Total Unusual Items Excluding Goodwill Net Income From Continuing Operation Net Minority Interest Reconciled Depreciation Reconciled Cost Of Revenue EBITDA EBIT Net Interest Income Interest Expense Interest Income Normalized Income Net Income From Continuing And Discontinued Operation Total Expenses Rent Expense Supplemental Diluted Average Shares Basic Average Shares Diluted EPS Basic EPS Diluted NI Availto Com Stockholders Net Income Common Stockholders Otherunder Preferred Stock Dividend Net Income Minority Interests Net Income Including Noncontrolling Interests Net Income Continuous Operations Tax Provision Pretax Income Other Non Operating Income Expenses Special Income Charges Other Special Charges Write Off Impairment Of Capital Assets Net Non Operating Interest Income Expense Total Other Finance Cost Interest Expense Non Operating Interest Income Non Operating Operating Income Operating Expense Other Operating Expenses Depreciation And Amortization In Income Statement Amortization Depreciation Income Statement Selling General And Administration General And Administrative Expense Rent And Landing Fees Gross Profit Cost Of Revenue Total Revenue Operating Revenue
2024-03-31T00:00:00 annual 0.38 0.00 84.31 1.26 1.26 22.07 44.48 91.62 85.57 41.08 -3.68 3.91 0.88 21.19 22.07 159.38 0.12 3.84 3.82 0.00 0.00 22.07 22.07 0.00 22.07 0.46 21.61 21.61 15.56 37.18 0.05 0.16 -0.16 0.00 0.00 -3.68 0.65 3.91 0.88 38.86 67.76 8.22 44.48 21.95 22.54 7.25 7.25 0.12 106.62 91.62 198.24 198.24
2023-03-31T00:00:00 annual 0.72 0.00 62.79 2.40 2.40 19.08 37.53 96.05 65.19 27.66 -2.55 2.67 0.38 17.40 19.08 159.56 0.33 3.62 3.51 0.00 0.00 19.08 19.08 0.00 19.08 4.15 14.93 14.93 10.06 25.00 0.44 0.00 0.00 0.00 0.00 -2.55 0.27 2.67 0.38 21.56 63.51 10.47 37.21 23.97 13.24 8.16 8.16 0.33 85.07 96.05 181.13 181.13
2022-03-31T00:00:00 annual -13.49 0.00 30.72 -44.98 -44.98 13.41 19.13 80.67 -14.27 -33.39 -2.30 2.48 0.31 44.90 13.41 107.27 0.65 3.37 3.12 0.00 0.00 13.41 13.41 0.00 13.41 53.10 -39.69 -39.69 3.82 -35.87 0.71 -45.11 45.11 0.00 0.00 -2.30 0.13 2.48 0.31 9.24 26.60 6.24 19.13 0.00 19.13 3.70 3.70 0.65 35.84 80.67 116.51 116.51
2021-03-31T00:00:00 annual -1.58 0.00 0.61 -32.40 -32.40 -42.93 18.77 64.07 -31.79 -50.56 -4.53 3.89 0.16 -12.11 -42.93 97.61 0.87 3.22 3.12 0.00 0.00 -42.93 -42.93 0.00 -42.93 8.86 -51.79 -51.79 -2.66 -54.44 0.46 -32.79 31.16 0.20 1.64 -4.53 0.81 3.89 0.16 -18.05 33.54 10.91 18.77 0.00 18.77 3.00 3.00 0.87 15.49 64.07 79.56 79.56
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

FII & DII Data (In Cr)

Date FII Gross Purchase FII Gross Sales FII Net Purchase / Sales DII Gross Purchase DII Gross Sales DII Net Purchase / Sales
2025-02-03 12,505.92 16,464.29 -3,958.37 19,319.48 16,611.25 2,708.23
2025-01-30 10,513.63 15,096.58 -4,582.95 13,934.35 11,768.46 2,165.89
2025-01-29 7,644.40 10,230.83 -2,586.43 12,871.38 11,078.67 1,792.71
2025-01-27 9,488.57 14,504.03 -5,015.46 16,503.43 9,861.28 6,642.15
2025-01-24 11,230.47 13,988.96 -2,758.49 12,835.41 10,433.10 2,402.31
2025-01-23 13,316.55 18,779.07 -5,462.52 14,412.73 10,700.18 3,712.55
2025-01-22 12,936.64 16,962.89 -4,026.25 15,437.18 11,796.96 3,640.22
Quarterly Results
Profit & Loss
Piotroski F-Score
6/9
0 1 2 3 4 5 6 7 8 9

Key Metrics

EPS

11.14

P/E

82.320465

P/B

7.208889

Dividend Yield

N/A

Market Cap

3,650.93 Cr.

Face Value

127.211

Book Value

127.211

ROE

18.32%

EBITDA Growth

108.91 Cr.

Debt/Equity

14.352

Short Term

Subscribe to unlock this feature

Medium Term

Subscribe to unlock this feature

Long Term

Subscribe to unlock this feature

Yearly Stock Performance Heatmap

Latest Updates

GENESYS News

Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI

Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:50

GENESYS News

Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends

"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:47

GENESYS News

FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore

Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:37

GENESYS News

Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal

The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:23

GENESYS News

Apple iPhone SE 4: Price To Features, 11 Things You Need To Know

iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:12

GENESYS News

Rupee Closed Weaker Against The US Dollar

The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 15:54

GENESYS News

Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45

Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:09

GENESYS News

War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel

The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:00

Popular Questions

How to Buy genesys Shares on Fincept?

You can buy Genesys International Corporation Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.

What is the Market Cap of genesys?

The market capitalization of Genesys International Corporation Limited is ₹3,651 Cr as of 05 Feb 2025.

What are the PE and PB ratios of Genesys International Corporation Limited?

The PE and PB ratios of Genesys International Corporation Limited are Not Available and 7.208889 respectively as of 05 Feb 2025.

What is the 52 Week High of Genesys International Corporation Limited?

The 52-week high of Genesys International Corporation Limited is ₹998.95 as of 05 Feb 2025.

What is the 52 Week Low of Genesys International Corporation Limited?

The 52-week low of Genesys International Corporation Limited is ₹407.2 as of 05 Feb 2025.

What are the earnings per share (EPS) for Genesys International Corporation Limited?

The Earnings Per Share (EPS) of Genesys International Corporation Limited is ₹11.14 as per the most recent quarterly results available on Fincept.

What is the ROE (Return on Equity) of Genesys International Corporation Limited?

The Return on Equity (ROE) of Genesys International Corporation Limited is 18.32% as per the most recent financial year data. Explore more on Fincept.

POLYMED

View Stock

JINDALPOLY

View Stock

VHLTD

View Stock

LOYALTEX

View Stock

MAHEPC

View Stock

TAJGVK

View Stock

ASIANENE

View Stock

RKFORGE

View Stock

SPMLINFRA

View Stock

NAVA

View Stock

KEEPLEARN

View Stock

GANGOTRI

View Stock

CONCORDBIO

View Stock

GODFRYPHLP

View Stock

GULFOILLUB

View Stock